Bayer unveils Calantic Digital Solutions, a new cloud-hosted platform delivering access to digital applications, including AI-enabled programs, for medical imaging. The offering contains tools to help triage critical patient findings for expedited review, improve lesion detection and automate tasks. With this launch, Bayer expands its radiology portfolio beyond contrast media, devices, software and services, with the ultimate goal of supporting healthcare professionals to aid in the detection of disease patterns throughout the patient’s journey.
The launch comes at a time when chronic diseases are on the rise, increasing the demand for medical imaging. With radiology’s increasing complexity, including a five-fold jump in the number of magnetic resonance imaging (MRI) images produced per scan, to meet workload demands, an average radiologist in some cases would need to interpret one image every 3-4 seconds in an 8-hour workday. Exacerbating this situation is a shortage of radiologists. Time pressure and workload contribute to the prevalence of burn-out among radiologists. In addition, data show the rate of diagnostic errors rises with long hours of overtime. Digital technologies can help manage the mounting workload of radiologists and their teams, ultimately striving to improve patient care.
“AI has the potential to transform healthcare, and, particularly in medical imaging, it can turn the growing amounts of data into value-adding insights to support radiologists and their teams in their decision-making,” says Dr. Ryan Lee, Chair, Department of Radiology, Einstein Healthcare Network, Philadelphia. “It is crucial to drive innovation in this area and broaden access to digital tools that can help address the rising demand for solutions which improve the speed and accuracy of diagnoses.”
The apps will be centered around three key areas to help manage efficiencies across the radiology workflow: triage apps to flag suspected pathologies and findings that warrant urgent review and treatment; detection apps to improve lesion detection; and quantification apps for automation of routine tasks.
“Built on our leading industry knowledge and deep medical understanding across a multitude of diagnostic and therapeutic areas, Calantic Digital Solutions underlines our commitment to continue accelerating innovation for the benefit of patients and their physicians,” says Gerd Krüger, Head of Radiology, Bayer Pharmaceuticals. “With Calantic Digital Solutions, we are entering the fastest growing segment in the radiology market and taking the next step from a product provider to a solution provider, following our mission to provide an ecosystem of third-party and Bayer products to deliver innovative disease-oriented solutions for radiologists and their teams.”
[Source(s): Bayer, Business Wire]